Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine vs PEFG in Resected Pancreatic Cancer
NCT00960284Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jun 2003
- Primary completion
- Jun 2009
- Modality
- Nanoparticles, DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132), epirubicin, fluorouracil, capecitabine in pancreatic adenocarcinoma (PDAC), sponsored by IRCCS Ospedale San Raffaele. Started Jun 2003; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)epirubicinfluorouracilcapecitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00960284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00960284.